Q-Line Biotech Board Approves 16th AGM, Director Reappointments, and Cost Auditor
Q-Line Biotech Ltd · Outcome · 05 Sept 2026, 11:45 pm
Q-Line Biotech Board Approves 16th AGM, Director Reappointments, and Cost Auditor Q-Line Biotech Limited’s Board approved the FY26 Board’s Report and convened its 16th AGM physically for 30th Sep'26 in Lucknow. The cut-off date for e-voting is 23rd Sep'26, with the remote e-voting window active from 27th Sep'26 to 29th Sep'26 via CDSL, scrutinized by M/s. MMA & Partners. Additionally, the Board recommended the re-appointment of Whole Time Directors Ajay Kumar Mahanty and Kuldeep Chowdhry (liable to retire by rotation) and approved M/s P S P & Associates as Cost Auditor for FY27.
Original exchange filing (PDF)
More announcements from Q-Line Biotech Ltd
- Q-Line Biotech Limited has informed the Exchange regarding 'Submission of audio recording of Earnings Conference Call-13.11.2026'. · 15 Nov 2026
- Q-Line Biotech Limited has informed the Exchange about Investor Presentation · 13 Nov 2026
- Q-Line Biotech Limited has informed the Exchange about General Updates · 13 Nov 2026
- Q-Line Biotech Limited has informed the Exchange regarding a press release dated November 12, 2026, titled "PRESS RELEASE ON FINANCIAL RESULTS 30 SEPTEMBER 2026.". · 13 Nov 2026
- Q-Line Biotech Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. · 13 Nov 2026
- Q-Line Biotech Limited has informed the Exchange regarding 'Board comments on fine levied by the Exchange'. · 13 Nov 2026
- Q-Line Biotech Limited has informed the Exchange about Schedule of meet · 13 Nov 2026
- Q-Line Biotech Limited has informed the Exchange about Board Meeting to be held on 12-Nov-2026 to consider and approve the Half Yearly Unaudited Financial results of the Company for the period ended September 2026 and Other business. · 12 Nov 2026
